Guides & references


PUBLISHED: 2017 CATEGORY: TYPE: External Link La vaccination : la mise à jour de l'immunisation des enfants néo-canadiens

La vaccination : la mise à jour de l'immunisation des enfants néo-canadiens

Lorsqu’on veut s’assurer qu’un enfant nouvellement arrivé au Canada a reçu tous les vaccins prévus, on fait face à des problèmes particuliers. L’examen médical aux fins de l’'immigration n’inclut pas la confirmation ou la mise à jour de la vaccination. Il ne faut pas présumer que les enfants nouvellement arrivés ont reçu tous les vaccins.

Corporate Authors: Société canadienne de pédiatrie
Publisher: Société canadienne de pédiatrie

PUBLISHED: 2017 CATEGORY: TYPE: External Link La vaccination contre le méningocoque du sérogroupe B : ce que le praticien doit savoir

La vaccination contre le méningocoque du sérogroupe B : ce que le praticien doit savoir

Au Canada, la plupart des méningococcies invasives sont désormais causées par des organismes du sérogroupe B. Un vaccin conçu contre ce sérogroupe (4CMenB) vient d'être homologué au Canada. Le présent document peut être utile aux cliniciens qui devront répondre aux questions des parents.

Authors: Robinson J
Corporate Authors: Société canadienne de pédiatrie, Comité des maladies infectieuses et d’immunisation
Publisher: Société canadienne de pédiatrie

PUBLISHED: 2017 CATEGORY: Health care providers TYPE: External Link National Association of Pharmacy Regulatory Authorities

National Association of Pharmacy Regulatory Authorities

Enhances the activities of the pharmacy regulatory authorities by: representing the common interests of the member organizations; serving as a national resource centre; and promoting the national implementation of progressive regulatory programs and standards.

Corporate Authors: National Association of Pharmacy Regulatory Authorities
Publisher: National Association of Pharmacy Regulatory Authorities

PUBLISHED: 2017 CATEGORY: TYPE: External Link Recommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) : Calendrier de vaccination du vaccin nonavalent contre le VPH à deux doses et utilisation des vaccins anti-VPH chez les populations immunodéprimées

Recommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) : Calendrier de vaccination du vaccin nonavalent contre le VPH à deux doses et utilisation des vaccins anti-VPH chez les populations immunodéprimées

La présente déclaration examine les données probantes concernant un calendrier de vaccination à deux doses du vaccin VPH9 et formule des recommandations; elle résume les données probantes obtenues dans le cadre d’une récente analyse documentaire du CCNI sur l’utilisation des vaccins contre le VPH chez les populations immunodéprimées et formule des recommandations sur l’utilisation du vaccin contre le VPH dans ces groupes.

Corporate Authors: Comité consultatif national de l'immunisation
Publisher: Agence de la santé publique du Canada

PUBLISHED: 2017 CATEGORY: TYPE: External Link Relevé des maladies transmissibles au Canada (RMTC)

Relevé des maladies transmissibles au Canada (RMTC)

Corporate Authors: Comité consultatif national de l'immunisation
Publisher: Agence de la santé publique du Canada

PUBLISHED: 2017 CATEGORY: Health care providers TYPE: External Link Updated Recommendations on Human Papillomavirus (HPV) Vaccines: 9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations

Updated Recommendations on Human Papillomavirus (HPV) Vaccines: 9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations

This statement reviews evidence for a 2-dose immunization schedule of the HPV9 vaccine, and provides recommendations; it summarizes evidence from a recent NACI Literature Review on the use of HPV vaccines in immunocompromised populations, and provides recommendations for HPV vaccine use in these groups.

Corporate Authors: National Advisory Committee on Immunization
Publisher: Public Health Agency of Canada

PUBLISHED: 2017 CATEGORY: Les fournisseurs de soins, Parents, Adultes TYPE: External Link Vaccination

Vaccination

Par leurs études et leurs avis, l’Institut national de santé publique et le Comité sur l’immunisation du Québec participent au maintien de la qualité du programme québécois d’immunisation. Voici réunies dans une même page, les plus récentes publications concernant la vaccination par thématiques et quelques ressources pertinentes.

Corporate Authors: Institut national de santé publique du Québec
Publisher: Institut national de santé publique du Québec

PUBLISHED: 2017 CATEGORY: Health care providers TYPE: External Link Vaccine Safety: Examine the Evidence

Vaccine Safety: Examine the Evidence

The safety and effectiveness of vaccines are under constant study. Because vaccines are designed to be given routinely during well-child care visits, they must be extraordinarily safe. Safety testing begins as soon as a new vaccine is contemplated, continues until it is approved by the FDA, and is monitored indefinitely after licensure. The American Academy of Pediatrics (AAP) works closely with the Centers for Disease Control and Prevention (CDC, US) to make recommendations for vaccine use.

Corporate Authors: American Academy of Pediatrics
Publisher: American Academy of Pediatrics

PUBLISHED: 2016 CATEGORY: Health care providers TYPE: External Link Are We Doing Enough? A status report on Canadian public policy and child and youth health

Are We Doing Enough? A status report on Canadian public policy and child and youth health

The Canadian Paediatric Society's biennial status report, "Are We Doing Enough?", evaluates public policies affecting children and youth in Canada. It charts how well provincial/territorial and federal governments use their legislative powers to promote specific health and safety issues affecting young people. The report helps governments – and health care providers working with them – to take steps to improve and advance their public agendas in four key areas, based on specific needs and best evidence. See specific section on Immunization.

Corporate Authors: Canadian Paediatric Society
Publisher: Canadian Paediatric Society

PUBLISHED: 2016 CATEGORY: Health care providers TYPE: External Link Assessing vaccine safety within Ontario's Universal Influenza Immunization Program, 2012-2013 to 2014-2015

Assessing vaccine safety within Ontario's Universal Influenza Immunization Program, 2012-2013 to 2014-2015

Objective: To summarize adverse events following immunization (AEFIs) reported after receipt of influenza vaccines administered within the Universal Influenza Immunization Program in Ontario.

Conclusion: This assessment found a low rate of reported adverse events following influenza vaccines administered in Ontario. Most reported events were mild and resolved completely. The findings were consistent with the very good safety profile of influenza vaccines.

Authors: Harris T et al.
Publisher: Public Health Agency of Canada